US · LYB · CHEMICALS - SPECIALTY
LyondellBasell Industries N.V. (LYB) intrinsic value and stock valuation
$55.84as of 2026-11-21 · Mkt cap 19.05B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
LyondellBasell Industries N.V. DCF and intrinsic value
InvestorsCraft values LYB with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from LYB’s statements →
LyondellBasell Industries N.V. Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- International Flavors & Fragrances Inc. (IFF) $79.62
- Reliance Steel & Aluminum Co. (RS) $398.46
- Dow Inc. (DOW) $29.03
- Sociedad Química y Minera de Chile S.A. (SQM) $46.97
- DuPont de Nemours, Inc. (DD) $145.43
- CF Industries Holdings, Inc. (CF) $115.53
- CEMEX, S.A.B. de C.V. (CX) $9.28
- RPM International Inc. (RPM) $102.54
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $30.2B | $40.3B | $41.1B | $50.5B | $46.2B |
| Operating income | -$-327M | $1.82B | $3.05B | $5.1B | $6.77B |
| Net income | -$-743M | $1.36B | $2.11B | $3.88B | $5.61B |
| EPSd | -$-2.31M | $4.17M | $6.48M | $11.8M | $16.8M |
| Operating cash flow | $2.26B | $3.82B | $4.94B | $6.12B | $7.7B |
| Capital expenditure | -$-1.88B | -$-1.84B | -$-1.53B | -$-1.89B | -$-1.96B |
| Free cash flow | $384M | $1.98B | $3.41B | $4.23B | $5.74B |
| Total assets | $34B | $35.7B | $37B | $36.4B | $36.7B |
| Total debt | $16B | $12.9B | $13B | $13.2B | $13.6B |
| Net debt | $12.5B | $9.55B | $9.61B | $11B | $12.1B |
| Total equity | $10.2B | $12.6B | $13.1B | $12.7B | $12B |
| Cash and short-term investments | $3.45B | $3.38B | $3.39B | $2.15B | $1.48B |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $30.2B | $40.3B | $41.1B | $50.5B | $46.2B |
| Cost of revenue | $27.4B | $35.7B | $35.8B | $43.8B | $37.4B |
| Gross profit | $2.72B | $4.56B | $5.26B | $6.6B | $8.78B |
| Research and development expenses | $138M | $135M | $130M | $124M | $124M |
| Selling, general and administrative expenses | $1.7B | $1.66B | $1.56B | $1.31B | $1.26B |
| Other expenses | $1.2B | $949M | $518M | $69M | $624M |
| Operating expenses | $3.04B | $2.75B | $2.21B | $1.5B | $2B |
| Cost and expenses | $30.5B | $38.5B | $38.1B | $45.4B | $39.4B |
| Interest income | $72M | $150M | $129M | $29M | $9M |
| Interest expense | $507M | $481M | $477M | $287M | $519M |
| Depreciation and amortization | $1.39B | $1.52B | $1.53B | $1.27B | $1.39B |
| Ebitda | $1.19B | $3.61B | $4.64B | $6.33B | $8.7B |
| Operating income | -$-327M | $1.82B | $3.05B | $5.1B | $6.77B |
| Total other income/expenses, net | -$-385M | -$-214M | -$-426M | -$-325M | $13M |
| Income before tax | -$-712M | $1.6B | $2.63B | $4.78B | $6.79B |
| Income tax expense | $79M | $240M | $501M | $882M | $1.16B |
| Net income | -$-743M | $1.36B | $2.11B | $3.88B | $5.61B |
| Weighted average shares outstanding | $322M | $325M | $325M | $327M | $334M |
| Weighted average diluted shares outstanding | $322M | $326M | $326M | $328M | $334M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $3.45B | $3.38B | $3.39B | $2.15B | $1.48B |
| Net receivables | $2.81B | $3.55B | $3.99B | $4.08B | $5.21B |
| Inventory | $3.6B | $4.66B | $4.77B | $4.8B | $4.9B |
| Total current assets | $10.9B | $12.3B | $13.2B | $11.8B | $12.2B |
| Property, plant and equipment, net | $17.3B | $16.5B | $17.1B | $17.1B | $16.5B |
| Goodwill and intangible assets | $1.16B | $2.14B | $2.29B | $2.49B | $2.57B |
| Long-term investments | $3.97B | $4.12B | $3.91B | $4.3B | $4.79B |
| Total non-current assets | $23.1B | $23.5B | $23.8B | $24.5B | $24.5B |
| Total assets | $34B | $35.7B | $37B | $36.4B | $36.7B |
| Accounts payable | $2.69B | $3.73B | $3.82B | $3.58B | $4.29B |
| Short-term debt | $1.18B | $972M | $1.26B | $1.13B | $704M |
| Deferred revenue | $113M | $110M | $175M | $167M | $169M |
| Total current liabilities | $6.13B | $6.71B | $7.15B | $6.76B | $7.23B |
| Long-term debt | $14.8B | $12B | $11.7B | $12.1B | $12.9B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $17.7B | $16.5B | $16.8B | $16.9B | $17.5B |
| Capital lease obligations | $1.33B | $1.77B | $1.77B | $1.85B | $1.99B |
| Total liabilities | $23.8B | $23.2B | $23.9B | $23.6B | $24.8B |
| Common stock | $19M | $19M | $19M | $19M | $19M |
| Retained earnings | $6.81B | $9.33B | $9.69B | $9.2B | $8.56B |
| Accumulated other comprehensive income (loss) | -$-1.31B | -$-1.53B | -$-1.48B | -$-1.37B | -$-1.8B |
| Total equity | $10.2B | $12.6B | $13.1B | $12.7B | $12B |
| Total investments | $3.96B | $4.12B | $3.91B | $4.3B | $4.8B |
| Total debt | $16B | $12.9B | $13B | $13.2B | $13.6B |
| Net debt | $12.5B | $9.55B | $9.61B | $11B | $12.1B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | -$-738M | $1.37B | $2.12B | $3.89B | $5.62B |
| Depreciation and amortization | $1.39B | $1.52B | $1.53B | $1.27B | $1.39B |
| Stock-based compensation | $91M | $91M | $0.00 | $70M | $66M |
| Change in working capital | $415M | $30M | $437M | $97M | $304M |
| Accounts receivable | $687M | $127M | $110M | $1.01B | -$-1.52B |
| Inventory | $945M | $25M | $18M | -$-91M | -$-742M |
| Accounts payable | -$-768M | -$-122M | $141M | -$-464M | $1.3B |
| Net cash provided by operating activities | $2.26B | $3.82B | $4.94B | $6.12B | $7.7B |
| Investments in property, plant and equipment | -$-1.88B | -$-1.84B | -$-1.53B | -$-1.89B | -$-1.96B |
| Acquisitions, net | -$-10M | $138M | $0.00 | -$-4M | -$-106M |
| Net cash used for investing activities | -$-1.78B | -$-1.85B | -$-1.78B | -$-1.98B | -$-1.5B |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-201M | -$-195M | -$-211M | -$-420M | -$-463M |
| Dividends paid | -$-1.76B | -$-1.72B | -$-1.61B | -$-3.25B | -$-1.49B |
| Net cash used for financing activities | -$-507M | -$-1.9B | -$-1.95B | -$-3.41B | -$-6.39B |
| Net change in cash | $61M | -$-17M | $1.25B | $679M | -$-288M |
| Cash at end of period | $3.45B | $3.39B | $3.41B | $2.16B | $1.48B |
| Operating cash flow | $2.26B | $3.82B | $4.94B | $6.12B | $7.7B |
| Capital expenditure | -$-1.88B | -$-1.84B | -$-1.53B | -$-1.89B | -$-1.96B |
| Free cash flow | $384M | $1.98B | $3.41B | $4.23B | $5.74B |
Line items
Line items
Line items
About LyondellBasell Industries N.V.
LyondellBasell Industries N.V., established in 2009 and based in Houston, Texas, operates as a prominent global chemical manufacturer with a significant international footprint, including the United States, Germany, Mexico, Italy, Poland, France, Japan, China, and the Netherlands. The company's diverse operations are organized into six distinct segments. Its core business involves the production and marketing of olefins and various polyolefins, such as high, low, and linear low-density polyethylene, along with polypropylene homopolymers and copolymers, for markets spanning the Americas, Europe, and Asia. LyondellBasell also focuses on intermediate chemicals and derivatives, offering products like propylene oxide, oxyfuels, styrene monomers, acetyls, and ethylene-based compounds. Furthermore, the company develops and sells advanced polymer solutions, including polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors, and powders. Its activities extend to refining crude oil into gasoline and distillates, as well as the development and licensing of chemical and polyolefin process technologies, alongside the manufacturing and sale of polyolefin catalysts.
- CEO
- Peter Z. E. Vanacker
- Employees
- 18.97K
- Beta
- 0.36
Included in
Explore
Frequently asked questions
What is the intrinsic value of LyondellBasell Industries N.V. (LYB)?
LyondellBasell Industries N.V. (LYB) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is LYB undervalued?
LYB trades at a price of $55.84 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.